|Articles|May 1, 2014
- BioPharm International-05-01-2014
- Volume 27
- Issue 5
BioPharm International, May 2014 Issue (PDF)
Click the title above to open the BioPharm International May 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Accelerated Stability Modelingover 11 years ago
Demand for New Vaccines Spurs Innovationover 11 years ago
Standardizing Practices for Disposablesover 11 years ago
Clinical Syringe Packages Increase Productivityover 11 years ago
Linking Drug Shortages and Quality Metricsover 11 years ago
Improving Protein Expression with Novel Systemsover 11 years ago
Integrated Single-Use Sterile and SIP Connector Provide Flexibilityover 11 years ago
India's Developing Market Offers OpportunitiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Next-Generation Modalities Drive New Antibody Discovery
3
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5
